Published mark
KORU Medical Systems, Inc.
NASDAQ: KRMD. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:3e3036f7-f637-4455-80a9-ac62575beb22
- SEC CIK
- 0000704440
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 17, 2026
- Newest evidence
- Apr 9, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Linda TharbySince Mar 12, 2026
- Chair
- Not published
- Independent
- 5 / 77 directors published
- Published claims
- 293 distinct sources
- Evidence records
- 80 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 8 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Adam Kalbermatten executive of KORU Medical Systems, Inc., effective 2026-03-12.
EffectiveEffective Mar 12, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Commercial Officer | Adam Kalbermatten | Mar 2026 | current | Source reportedE3 |
| Chief Operating Officer | Christopher Pazdan | Mar 2026 | current | Source reportedE4 |
| Chief Technology Officer | Eric Schiller | Mar 2026 | current | Source reportedE5 |
| Chief Executive Officer and President | Linda Tharby | Mar 2026 | current | Source reportedE6 |
| Chief Financial Officer, Secretary and Treasurer | Tim Adams | Mar 2026 | current | Source reportedE7 |
Board of directors
Evidence7 directors published. 5 of 7 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Donna French, PhD | Independent | 2021 | Nominating and Governance | Source reportedE2 |
| Edward Wholihan | Not independent | 2023 | None published | Source reportedE2 |
| Joseph M. Manko, Jr. | Independent | 2016 | AuditAudit; Compensation · Chair; Nominating and GovernanceCompensation, chairNominating and Governance | Source reportedE2 |
| Linda Tharby | Not independent | 2022 | None published | Source reportedE2 |
| R. John Fletcher | Independent | 2019 | AuditAudit; Compensation; Nominating and Governance · ChairCompensationNominating and Governance, chair | Source reportedE2 |
| Robert A. Cascella | Independent | 2022 | Audit, chairAudit · Chair | Source reportedE2 |
| Shahriar (Shar) Matin | Independent | 2021 | Compensation, chairCompensation · Chair; Nominating and GovernanceNominating and Governance | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Robert A. Cascella | Robert A. Cascella, Joseph M. Manko, Jr., R. John Fletcher | Not described in the published record |
| Audit · Chair | Not published | Robert A. Cascella | Not described in the published record |
| Audit; Compensation · Chair; Nominating and Governance | Not published | Joseph M. Manko, Jr. | Not described in the published record |
| Audit; Compensation; Nominating and Governance · Chair | Not published | R. John Fletcher | Not described in the published record |
| Compensation | Shahriar (Shar) Matin | Joseph M. Manko, Jr., Shahriar (Shar) Matin, R. John Fletcher | Not described in the published record |
| Compensation · Chair; Nominating and Governance | Not published | Shahriar (Shar) Matin | Not described in the published record |
| Nominating and Governance | R. John Fletcher | R. John Fletcher, Donna French, PhD, Joseph M. Manko, Jr., Shahriar (Shar) Matin | Not described in the published record |
Committee RecordAudit: Chair Robert A. Cascella; Members Robert A. Cascella (Chair); Joseph M. Manko, Jr.; R. John Fletcher
Committee AppointmentRobert A. Cascella: chair, Audit
Committee AppointmentJoseph M. Manko, Jr.: member, Audit
Committee AppointmentR. John Fletcher: member, Audit
Committee RecordCompensation: Chair Joseph M. Manko, Jr.; Shahriar (Shar) Matin; Members Joseph M. Manko, Jr. (Chair); Shahriar (Shar) Matin (Chair); R. John Fletcher
Committee AppointmentJoseph M. Manko, Jr.: chair, Compensation
Committee AppointmentShahriar (Shar) Matin: chair, Compensation
Committee AppointmentR. John Fletcher: member, Compensation
Committee RecordNominating and Governance: Chair R. John Fletcher; Members R. John Fletcher (Chair); Donna French, PhD; Joseph M. Manko, Jr.; Shahriar (Shar) Matin
Committee AppointmentR. John Fletcher: chair, Nominating and Governance
Committee AppointmentDonna French, PhD: member, Nominating and Governance
Committee AppointmentJoseph M. Manko, Jr.: member, Nominating and Governance
Committee AppointmentShahriar (Shar) Matin: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerLinda Tharby, Chief Executive Officer and President, from Mar 12, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingKRMD (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 17, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameKORU Medical Systems, Inc.
Entity StatusPublic listing published
Published FactUS
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Adam KalbermattenChief Commercial Officercompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:12
- Christopher PazdanChief Operating Officercompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:13
- Eric SchillerChief Technology Officercompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:14
- Linda TharbyChief Executive Officer and President; Directorcompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:15, company:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:8
- Tim AdamsChief Financial Officer, Secretary and Treasurercompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:16
- Donna French, PhDDirectorcompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:5
- Edward WholihanDirectorcompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:6
- Joseph M. Manko, Jr.Directorcompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:7
- R. John FletcherDirectorcompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:9
- Robert A. CascellaDirectorcompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:10
- Shahriar (Shar) MatinDirectorcompany:3e3036f7-f637-4455-80a9-ac62575beb22:leadership_role:11
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 8 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 17, 2026. Cited by 4 Claims.
- E2sec proxy. Published Apr 9, 2026. Retrieved Apr 24, 2026. Cited by 7 Claims.
- E3sec filing. Published Mar 12, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E4sec filing. Published Mar 12, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E5sec filing. Published Mar 12, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E6sec filing. Published Mar 12, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E7sec filing. Published Mar 12, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E8board_seats. board seats. Cited by 13 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 17, 2026- Adam Kalbermatten executive of KORU Medical Systems, Inc., effective 2026-03-12.
- Christopher Pazdan executive of KORU Medical Systems, Inc., effective 2026-03-12.
- Eric Schiller executive of KORU Medical Systems, Inc., effective 2026-03-12.
- Linda Tharby executive of KORU Medical Systems, Inc., effective 2026-03-12.
- Tim Adams executive of KORU Medical Systems, Inc., effective 2026-03-12.
- Edward Wholihan seat on KORU Medical Systems, Inc., effective 2023-01-01.
- Linda Tharby seat on KORU Medical Systems, Inc., effective 2022-01-01.
- Robert A. Cascella seat on KORU Medical Systems, Inc., effective 2022-01-01.
- Audit · Chair committee of KORU Medical Systems, Inc., effective 2022-01-01.
- Robert A. Cascella member of Audit · Chair, effective 2022-01-01.
- Donna French, PhD seat on KORU Medical Systems, Inc., effective 2021-01-01.
- Shahriar (Shar) Matin seat on KORU Medical Systems, Inc., effective 2021-01-01.
- Compensation · Chair; Nominating and Governance committee of KORU Medical Systems, Inc., effective 2021-01-01.
- Shahriar (Shar) Matin member of Compensation · Chair; Nominating and Governance, effective 2021-01-01.
- Donna French, PhD member of Nominating and Governance, effective 2021-01-01.
- R. John Fletcher seat on KORU Medical Systems, Inc., effective 2019-01-01.
- Audit; Compensation; Nominating and Governance · Chair committee of KORU Medical Systems, Inc., effective 2019-01-01.
- R. John Fletcher member of Audit; Compensation; Nominating and Governance · Chair, effective 2019-01-01.
- Joseph M. Manko, Jr. seat on KORU Medical Systems, Inc., effective 2016-01-01.
- Audit; Compensation · Chair; Nominating and Governance committee of KORU Medical Systems, Inc., effective 2016-01-01.
- Joseph M. Manko, Jr. member of Audit; Compensation · Chair; Nominating and Governance, effective 2016-01-01.